• Japanese scientists have achieved a remarkable breakthrough by transforming live insects into chemical reactors capable of producing advanced materials.

    In a study conducted at RIKEN's Pioneering Research Institute and the Center for Sustainable Resource Science, researchers used tobacco cutworm caterpillars to process a synthetic nanocarbon compound called [6]MCPP.

    When fed this molecule, the caterpillars' natural digestive enzymes—particularly cytochrome P450 variants CYP X2 and CYP X3—converted it into a new oxygenated version with fluorescent properties, known as [6]MCPP-oxylene.

    This transformation occurred within just two days and significantly outperformed attempts made in laboratory conditions using traditional chemical processes.

    This approach, termed “in-insect synthesis,” opens a new frontier in biomanufacturing.

    Insects like caterpillars offer a naturally evolved biochemical environment that can conduct complex transformations more efficiently than current synthetic chemistry.

    The oxygen-doped nanocarbon molecules produced in this way are especially valuable due to their optical and conductive characteristics, with potential applications in high-tech fields such as battery technology, aerospace, and optical devices.

    While the results are promising, they also raise ethical and ecological questions.

    Turning insects into bio-factories introduces concerns about the long-term impact on ecosystems, the welfare of the modified insects, and the potential risks of uncontrolled genetic or biochemical alterations.

    Nevertheless, this innovation represents a major step toward more sustainable and biologically inspired manufacturing methods in material science.
    Japanese scientists have achieved a remarkable breakthrough by transforming live insects into chemical reactors capable of producing advanced materials. In a study conducted at RIKEN's Pioneering Research Institute and the Center for Sustainable Resource Science, researchers used tobacco cutworm caterpillars to process a synthetic nanocarbon compound called [6]MCPP. When fed this molecule, the caterpillars' natural digestive enzymes—particularly cytochrome P450 variants CYP X2 and CYP X3—converted it into a new oxygenated version with fluorescent properties, known as [6]MCPP-oxylene. This transformation occurred within just two days and significantly outperformed attempts made in laboratory conditions using traditional chemical processes. This approach, termed “in-insect synthesis,” opens a new frontier in biomanufacturing. Insects like caterpillars offer a naturally evolved biochemical environment that can conduct complex transformations more efficiently than current synthetic chemistry. The oxygen-doped nanocarbon molecules produced in this way are especially valuable due to their optical and conductive characteristics, with potential applications in high-tech fields such as battery technology, aerospace, and optical devices. While the results are promising, they also raise ethical and ecological questions. Turning insects into bio-factories introduces concerns about the long-term impact on ecosystems, the welfare of the modified insects, and the potential risks of uncontrolled genetic or biochemical alterations. Nevertheless, this innovation represents a major step toward more sustainable and biologically inspired manufacturing methods in material science.
    Like
    1
    0 Commentaires 0 Parts 26KB Vue
  • The world’s first lung cancer vaccine, known as CIMAvax-EGF, has entered clinical trials in seven countries, marking a major milestone in cancer treatment.

    Unlike preventive vaccines, this is a therapeutic vaccine designed to treat existing lung cancer by targeting and neutralizing epidermal growth factor (EGF) — a protein that promotes the growth of cancer cells.

    Developed in Cuba, the vaccine has already shown promising results in extending survival for patients with advanced non-small cell lung cancer (NSCLC).

    Now, international clinical trials are being launched in the United States, United Kingdom, Japan, Cuba, Serbia, Bosnia and Herzegovina, and Colombia.

    The U.S. trials are being led by Roswell Park Comprehensive Cancer Center in partnership with Cuban researchers.

    This groundbreaking collaboration could offer a new path forward in cancer immunotherapy, particularly for one of the deadliest cancers globally.

    If successful, the vaccine may significantly improve outcomes and quality of life for lung cancer patients around the world.
    The world’s first lung cancer vaccine, known as CIMAvax-EGF, has entered clinical trials in seven countries, marking a major milestone in cancer treatment. Unlike preventive vaccines, this is a therapeutic vaccine designed to treat existing lung cancer by targeting and neutralizing epidermal growth factor (EGF) — a protein that promotes the growth of cancer cells. Developed in Cuba, the vaccine has already shown promising results in extending survival for patients with advanced non-small cell lung cancer (NSCLC). Now, international clinical trials are being launched in the United States, United Kingdom, Japan, Cuba, Serbia, Bosnia and Herzegovina, and Colombia. The U.S. trials are being led by Roswell Park Comprehensive Cancer Center in partnership with Cuban researchers. This groundbreaking collaboration could offer a new path forward in cancer immunotherapy, particularly for one of the deadliest cancers globally. If successful, the vaccine may significantly improve outcomes and quality of life for lung cancer patients around the world.
    Like
    1
    0 Commentaires 0 Parts 25KB Vue
  • In a historic medical breakthrough, a surgeon based in Rome successfully performed a robotic prostate surgery on a patient located over 8,000 kilometers away in Beijing. Using advanced telesurgery systems and ultra-low-latency 5G networks, the operation marked the world’s first transcontinental robotic procedure—proving that precision medicine now knows no borders.

    The da Vinci surgical system transmitted the surgeon’s movements in real-time with millisecond-level delay, enabling unprecedented accuracy and responsiveness. Experts say this achievement paves the way for cross-border surgeries in conflict zones, remote villages, and even space missions. The future of surgery is no longer just in the room—it’s global.

    #RemoteSurgery #MedicalInnovation #Telesurgery #5GHealthTech #GlobalMedicine
    In a historic medical breakthrough, a surgeon based in Rome successfully performed a robotic prostate surgery on a patient located over 8,000 kilometers away in Beijing. Using advanced telesurgery systems and ultra-low-latency 5G networks, the operation marked the world’s first transcontinental robotic procedure—proving that precision medicine now knows no borders. The da Vinci surgical system transmitted the surgeon’s movements in real-time with millisecond-level delay, enabling unprecedented accuracy and responsiveness. Experts say this achievement paves the way for cross-border surgeries in conflict zones, remote villages, and even space missions. The future of surgery is no longer just in the room—it’s global. #RemoteSurgery #MedicalInnovation #Telesurgery #5GHealthTech #GlobalMedicine
    Like
    1
    0 Commentaires 0 Parts 25KB Vue
  • Physicists at Loughborough University have built the world's smallest violin using advanced nanolithography, a technique for etching incredibly tiny structures. The platinum-crafted violin measures just 35 microns long—smaller than the width of a single human hair—and was created to demonstrate the precision of their new nanoscale fabrication tools. It’s a playful yet powerful symbol of how far nanotechnology has come.

    Though it doesn’t make music, this microscopic marvel could pave the way for breakthroughs in nanoengineering, where such precision is crucial in fields like microelectronics, medical diagnostics, and materials science. It also offers a whimsical reminder that innovation isn’t just functional—it can be artistic too.

    #Nanotech #SmallestViolin #MicroscaleEngineering #LoughboroughUniversity #FutureTech
    Physicists at Loughborough University have built the world's smallest violin using advanced nanolithography, a technique for etching incredibly tiny structures. The platinum-crafted violin measures just 35 microns long—smaller than the width of a single human hair—and was created to demonstrate the precision of their new nanoscale fabrication tools. It’s a playful yet powerful symbol of how far nanotechnology has come. Though it doesn’t make music, this microscopic marvel could pave the way for breakthroughs in nanoengineering, where such precision is crucial in fields like microelectronics, medical diagnostics, and materials science. It also offers a whimsical reminder that innovation isn’t just functional—it can be artistic too. #Nanotech #SmallestViolin #MicroscaleEngineering #LoughboroughUniversity #FutureTech
    Like
    1
    0 Commentaires 0 Parts 24KB Vue
  • In a revolutionary advancement, scientists at Newcastle University have successfully 3D-printed a living human cornea using stem cells and a bio-ink made from alginate (derived from seaweed) and collagen. This printable mixture maintains both the softness needed for printing and the structural integrity required to form a usable cornea. Remarkably, the printing process takes under 10 minutes.

    What makes this breakthrough even more powerful is its customization. By scanning a patient’s eye, doctors can print a perfectly sized and shaped cornea. With over 10 million people globally affected by corneal blindness and a dire shortage of donor tissue, this innovation could one day allow hospitals to print corneas on demand—offering sight-saving treatment to millions.

    #3DPrinting #MedicalInnovation #StemCellResearch #BlindnessCure #FutureOfMedicine
    In a revolutionary advancement, scientists at Newcastle University have successfully 3D-printed a living human cornea using stem cells and a bio-ink made from alginate (derived from seaweed) and collagen. This printable mixture maintains both the softness needed for printing and the structural integrity required to form a usable cornea. Remarkably, the printing process takes under 10 minutes. What makes this breakthrough even more powerful is its customization. By scanning a patient’s eye, doctors can print a perfectly sized and shaped cornea. With over 10 million people globally affected by corneal blindness and a dire shortage of donor tissue, this innovation could one day allow hospitals to print corneas on demand—offering sight-saving treatment to millions. #3DPrinting #MedicalInnovation #StemCellResearch #BlindnessCure #FutureOfMedicine
    Like
    1
    0 Commentaires 0 Parts 24KB Vue
Plus de résultats